# Sertraline Hydrochloride

NDC: 69097-451
Generic name: Sertraline Hydrochloride
Labeler / Manufacturer: Cipla USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20250717

FDA application: ANDA218853

## Active ingredients

- SERTRALINE HYDROCHLORIDE: 200 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69097-451"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69097-451
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3a3efb5f-b24a-438d-9253-371ff3b5417d